Climb Bio, Inc. (CLYM)
10.94
-0.13
(-1.17%)
USD |
NASDAQ |
Oct 02, 16:00
11.10
+0.16
(+1.46%)
Pre-Market: 08:59
Climb Bio Total Liabilities (Quarterly) : 6.747M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.747M |
| March 31, 2026 | 4.287M |
| December 31, 2025 | 7.269M |
| September 30, 2025 | 5.301M |
| June 30, 2025 | 6.622M |
| March 31, 2025 | 7.355M |
| December 31, 2024 | 5.306M |
| September 30, 2024 | 3.423M |
| June 30, 2024 | 3.741M |
| March 31, 2024 | 2.95M |
| December 31, 2023 | 2.87M |
| Date | Value |
|---|---|
| September 30, 2023 | 2.993M |
| June 30, 2023 | 3.773M |
| March 31, 2023 | 5.225M |
| December 31, 2022 | 6.277M |
| September 30, 2022 | 6.499M |
| June 30, 2022 | 7.87M |
| March 31, 2022 | 7.277M |
| December 31, 2021 | 6.038M |
| September 30, 2021 | 5.59M |
| June 30, 2021 | 5.713M |
| March 31, 2021 | 4.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 1.843M |
| Cullinan Therapeutics, Inc. | 42.03M |
| Q32 Bio, Inc. | 9.962M |
| Artiva Biotherapeutics, Inc. | 21.13M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 246.29M |
| Shareholders Equity (Quarterly) | 239.55M |
| Debt to Equity Ratio | 0.0055 |
| Current Ratio | 31.45 |
| Net Debt Paydown Yield | -0.02% |